생몰정보
소속
직위
직업
활동분야
주기
서지
국회도서관 서비스 이용에 대한 안내를 해드립니다.
검색결과 (전체 1건)
원문 있는 자료 (1) 열기
원문 아이콘이 없는 경우 국회도서관 방문 시 책자로 이용 가능
목차보기더보기
표제지
목차
제출문 2
중국 3
General facts: Country & population 4
General facts: Now the world's 2nd largest economy entity(이미지참조) 5
General facts: Deficient and unbalanced medical resource 6
General facts: New Healthcare and Financing System 7
General facts: Health care environment 8
General facts: Regulatory environment 9
General facts: Regulatory environment (con't) 10
General facts: Clinical trial environment 11
General facts: Clinical trial environment (IND/IRB process) 12
General facts: Drug registration process 13
General factors: Pharma market in China 14
IMS Audited + Unaudited markets 15
Pharma growth expected at 3-6% CAGR to 2015 with value worth over US$ 1 trillion 15
A new world order will evolve through 2015 posing future investment decisions for multinationals 16
Oncology is now the largest pharma sector and it is still growing 17
Cancer facts: General Epidemiology of common cancers in china 18
Cancer facts: Cancer Incidence-Male 19
Cancer facts: Cancer Incidence-Female 20
Incidence of Liver Cancer 21
Gastric Cancer 21
Incidence of Nasopharyngeal Cancer 22
NHL subtype: WHO classification (China V.S US) 23
NSCLC subtype: Biomarker expression(China V.S US) 24
General facts: Cancer screening 25
General facts: Cancer treatment 26
Current situation: diversified 26
Deficiency 26
General facts: Cancer survival 27
General facts: Cancer survival (5-year survival) 28
General facts: Outstanding centers 29
General facts: Opportunities/challenges for Phase I Study 30
Regulation 30
Clinical study capacity 30
General facts: Opportunities for Phase I Study: new facilities 31
Cancer of interest 32
일본 33
Japan Overview 34
Proportion of Elderly Population by Country 35
Comparison in life expectancy 36
Trend in Medical Expenditure in Japan 37
Reimbursement system 38
Copayments made by members 38
High Cost Medical Treatment System 39
Pricing system 40
Comparator Pricing Method (I) 41
Comparator Pricing Method (II) 43
This method is applied to new drugs without innovativeness. 43
Basic calculation method 43
Cost Calculation Method 44
Foreign Price Adjustment 45
Price Listing Procedure for New Drugs 46
NHI price revision 47
Concept of "premium for promotion of new drug discovery and resolution of unapproved drugs/indications" 48
Outline of "premium for promotion of new drug discovery and resolution of unapproved drugs/indications" 49
Regulatory Authorities Roles and Responsibilities 50
MHLW (Ministry of Health, Labour and Welfare) 50
PMDA (KIKO, Pharmaceuticals and Medical Devices Agency) 51
Current Review System (review and consultation) 52
CTs with anti-cancer drugs are increasing in Japan 53
Global studies are increasing in Japan 54
GSK-J CTs by Type (as of 28-Feb-2011) 55
General factors: Sales trend in anti-cancer drug market 56
General factors: Sales trend in pharma market in Japan 57
Cancer incidence and mortality rates 58
Comparisons in 5yr-Survival by legion 59
Cancer screening 60
한국 61
General facts : North East Asia 62
North East Asia: Gastric Cancer 66
Korea is located between China and Japan, two of the world's largest economies 67
Rapidly Aging Population 68
Korea Cancer Incidence - 2009 (National Health Insurance) 69
Pharma market of Korea 70
One of the Fastest Growing Pharma Markets 71
Continuous growth in Korea 72
Brand Leadership in EMAP Markets 73
Overall Oncology Market - Total Incidence 74
Major Cancer Types' Incidence Trend: 1999-2008 75
Major Cancer Types' mortality Trend: 2003-2008 76
Cancer incidence : Korea GLOBOCAN 2008 77
Cancer incidence : Korea 80
Cancer survival 82
Cancer screening 83
Regulatory Guideline-IND 84
IND / IRB Process 85
Clinical Research Infrastructure in Korea 86
Korea R&D Environment 88
Next Growth Engine of KOREA - BT the "Green Industry" 89
Government Initiative-KoNECT 90
Trends of Clinical Study in Korea 92
Characteristics of Clinical Trials in Korea; 2009-2010 93
Current Korea Position in Industry Sponsored Clinical Trials 94
Industry sponsored trials(Top 30 cities) 95
TA Distribution of Global Trials in Korea 96
Korean Cancer Study Group 97
Korean Cancer Study Group(1) 98
Korean Cancer Study Group(2) 99
Major Hospitals 100
Seoul National University Hospital(1) 101
Seoul National University Hospital(2) 102
Seoul National University Hospital(3) 104
Seoul National University Hospital(4) 105
Yonsei Univ. Health System-Severance Hospital (1) 106
Severance Hospital (2) 107
Severance Hospital (3) 108
Asan Medical Center (1) 109
Asan Medical Center (2) 110
Asan Medical Center (3) 111
Samsung Medical Center (1) 112
Samsung Medical Center (2) 113
Samsung Medical Center (4) 114
Samsung Medical Center (5) 115
National Cancer Center (1) 116
National Cancer Center (2) 117
National Cancer Center (3) 118
Oncology Research in Korea 119
Leading Position in Global Clinical Studies - Oncology 120
Korea as a Major Player in Multinational Trials in Regionally Common Cancers 121
대만 122
Taiwan Overview 123
Life Expectancy in Taiwan 2010 124
Birth Rate in North East Asia 125
Predicted Trend of Taiwan Population Change 126
Population Demography of Taiwan in 2008 127
Taiwan Cancer Registry 128
Registry structure and methods 128
Interpreting the results 128
Use of the data 128
Top 10 Cancer Incidence Rates per 100,000 in 2008(only invasive cancer) 129
Top 10 Cancer Incidence Rates per 100,000 in 2008(carcinoma in situ and invasive cancers) 130
Top 10 Cancer Mortality Rates per 100,000 in 2008 131
Leading Cause of Death due to Cancer in Taiwan 2009 & 2010 132
Relative Survival Rate of New-diagnosed Cancer Case (%) Taiwan Top 10 Cancer, 2004-2008 (only invasive cancer) 133
Taiwan Rx: A Hospital market 134
Taiwan Healthcare Providers 135
Healthcare Environment- NHI: Full Healthcare Coverage with Low Investment (I) 136
NDA/BLA Registration Process 137
Healthcare System under the National Health Insurance (NHI) 138
Pricing & Reimbursement Environment 139
이용현황보기
가상서가
원문구축 및 2018년 이후 자료는 524호에서 직접 열람하십시요.
도서위치안내: / 서가번호:
우편복사 목록담기를 완료하였습니다.
* 표시는 필수사항 입니다.
* 주의: 국회도서관 이용자 모두에게 공유서재로 서비스 됩니다.
저장 되었습니다.
로그인을 하시려면 아이디와 비밀번호를 입력해주세요. 모바일 간편 열람증으로 입실한 경우 회원가입을 해야합니다.
공용 PC이므로 한번 더 로그인 해 주시기 바랍니다.
아이디 또는 비밀번호를 확인해주세요